Physician profile
Benjamin Winders
NPI 1033385349
$12,582.85
in general payments reported to CMS, 2019-2025
37 companies · $2,305 in 2025
The $2,305 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.57 · 2020: $79.14 · 2021: $1,026 · 2022: $2,504 · 2023: $4,373 · 2024: $2,244 · 2025: $2,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,278 · Travel and Lodging: $1,644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,278.02 |
| Travel and Lodging | $1,644.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,076.53 | 2022-2025 | Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $1,685.59 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,447.14 | 2021-2025 | Cardiomems, Gallant, Triclip |
| Shockwave Medical, INC | $1,119.80 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $705.71 | 2019-2025 | |
| Amgen INC. | $698.70 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $408.40 | 2022-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $251.53 | 2024-2025 | |
| Boston Scientific Corporation | $245.98 | 2022-2025 | Accolade Sr, Synergy, Watchman Access System |
| Penumbra, INC. | $169.25 | 2025 | Indigo System |
| Novo Nordisk INC | $149.59 | 2022-2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $141.27 | 2021-2025 | Farxiga, Brilinta |
| Biotronik INC. | $140.68 | 2021 | |
| Janssen Pharmaceuticals, INC | $138.60 | 2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $125.90 | 2022-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $125.22 | 2023-2025 | Onpattro |
| Esperion Therapeutics, INC. | $98.21 | 2021 | |
| Biosense Webster, INC. | $89.85 | 2025 | Carto 3 |
| Angiodynamics, INC. | $73.93 | 2025 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $71.09 | 2021-2024 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $65.03 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $64.99 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.38 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $59.87 | 2024 | |
| Irhythm Technologies, INC. | $58.43 | 2024 | Zio Xt Patch, Zio Monitor |
| Inspire Medical Systems, INC. | $54.29 | 2024 | Inspire |
| Acist Medical Systems, INC. | $37.21 | 2024-2025 | |
| Cardiovascular Systems INC. | $35.52 | 2021 | |
| Stryker Corporation | $33.24 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Vital Connect, INC | $22.36 | 2023 | Vitalpatch Rtm |
| Avanir Pharmaceuticals, INC. | $22.02 | 2019 | |
| Lantheus Medical Imaging, INC. | $21.93 | 2023 | Definity |
| Bolton Medical INC | $20.40 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Kowa Pharmaceuticals America, INC. | $19.28 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.94 | 2021 | |
| Azurity Pharmaceuticals, INC. | $15.07 | 2023 | Edarbi |
| Inari Medical, INC. | $13.92 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Winders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.